Abiopharma

🔍 Seckler Michael David (Executive)

Company: CorMedix Inc. (CRMD)

Report Date: 2026-01-08

Detailed Transactions and Holdings:

• Acquired 133,156 shares of Common Stock (Direct)
  Date: 2026-01-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 133,156.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: These Restricted Stock Units were granted on 01/08/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.